Real-time prescription monitoring - Victoria

On completion of this module you should be able to:

1. List key rationale behind the introduction of SafeScript to monitor supply of Schedule 8 and selected Schedule 4 high-risk medicines
2. Describe the benefits of the SafeScript system for clinical practice when prescribing Schedule 8 and selected Schedule 4 high-risk medicines
3. Describe how SafeScript will benefit safety for patients currently taking or commencing treatment with high-risk medicines
4. Identify approaches to managing and maintaining patient privacy when using SafeScript, and when communicating with patients and other health professionals
5. Identify key regulatory requirements relating to SafeScript implementation and what they mean in practice.

On completion of this module you should be able to:

1. List key rationale behind the introduction of SafeScript to monitor supply of Schedule 8 and selected Schedule 4 high-risk medicines
2. Describe the benefits of the SafeScript system for clinical practice when dispensing Schedule 8 and selected Schedule 4 high-risk medicines
3. Describe how SafeScript will benefit safety for patients currently taking or commencing treatment with high-risk medicines
4. Identify approaches to managing and maintaining patient privacy when using SafeScript, and when communicating with patients and prescribers
5. Identify key regulatory requirements relating to SafeScript implementation and what they mean in practice.

On completion of this module you should be able to:

1. Describe what is involved in safely and appropriately prescribing the high-risk medicines selected for monitoring through SafeScript
2. Determine the most appropriate management approach when concerns arise about the safety of patients using high-risk medicines
3. Identify effective, evidence-based non-pharmacological management options for chronic pain, insomnia and anxiety to suggest to patients to help manage their condition
4. Explain the appropriate place in therapy for high-risk medicines in the management of chronic pain, insomnia and anxiety
5. Implement the key steps involved in prescribing medication-assisted treatment for opioid dependence (MATOD) for patients with opioid dependence.

On completion of this module you should be able to:

1. List the steps involved in safe and appropriate dispensing of high-risk medicines selected for monitoring through SafeScript
2. Determine the most appropriate patient management approach when concerns arise about the safety of patients using high-risk medicines
3. Identify effective, evidence-based non-pharmacological management options for chronic pain, insomnia and anxiety to suggest to patients to help manage their condition
4. Explain the appropriate place in therapy for high-risk medicines in the management of chronic pain, insomnia and anxiety
5. Outline the key benefits of offering medication-assisted treatment for opioid dependence (MATOD) dispensing services for patients with opioid dependence in the community.

On completion of this module you should be able to:

1. Identify the elements of best practice communication that consider the individual needs of patients when discussing high-risk prescription medicines
2. Apply effective communication strategies and techniques to explain the risks of long-term use and dependence before prescribing high-risk medicines
3. Implement practice policies, set behaviour standards and use de-escalation techniques to reduce risks for health professionals and patients in challenging situations
4. Determine best practice follow-up protocols for patients who have high-risk use or are dependent on high-risk medicines. These may include specialist referrals.

On completion of this module you should be able to:

1. Identify the elements of best practice communication that consider the individual needs of patients when discussing high-risk prescription medicines
2. Apply effective communication strategies and techniques to explain the risks of long-term use and dependence before dispensing high-risk medicines
3. Implement pharmacy policies, set behaviour standards and use de-escalation techniques to reduce risks for health professionals and patients in challenging situations
4. Develop and enact a follow-up protocol for patients who have high-risk use or are dependent on high-risk medicines.